P Schipper

3.1k total citations
34 papers, 2.4k citations indexed

About

P Schipper is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, P Schipper has authored 34 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Infectious Diseases, 17 papers in Virology and 8 papers in Epidemiology. Recurrent topics in P Schipper's work include HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (13 papers) and HIV/AIDS Research and Interventions (8 papers). P Schipper is often cited by papers focused on HIV Research and Treatment (17 papers), HIV/AIDS drug development and treatment (13 papers) and HIV/AIDS Research and Interventions (8 papers). P Schipper collaborates with scholars based in Netherlands, United States and Germany. P Schipper's co-authors include Rob Schuurman, Monique Nijhuis, Charles A. Boucher, Leontine J. R. van Elden, Anton M. van Loon, Jan Albert, Dorien de Jong, Remko van Leeuwen, Mark A. Wainberg and N. Cammack and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and Scientific Reports.

In The Last Decade

P Schipper

34 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P Schipper Netherlands	20	1.7k	1.3k	797	299	170	34	2.4k
D. D. Richman United States	26	1.6k 1.0×	2.0k 1.5×	1.1k 1.4×	527 1.8×	112 0.7×	44	3.2k
Harold Burger United States	28	1.3k 0.8×	1.7k 1.3×	470 0.6×	414 1.4×	83 0.5×	63	2.3k
Arno C. Andeweg Netherlands	27	951 0.6×	362 0.3×	841 1.1×	345 1.2×	113 0.7×	54	2.1k
John Frater United Kingdom	28	1.3k 0.8×	1.7k 1.3×	502 0.6×	465 1.6×	110 0.6×	100	2.9k
Valérie Courgnaud France	24	894 0.5×	1.6k 1.2×	901 1.1×	317 1.1×	73 0.4×	47	2.3k
M Bendinelli Italy	21	327 0.2×	790 0.6×	1.0k 1.3×	203 0.7×	163 1.0×	101	1.7k
Willy Bogers Netherlands	22	457 0.3×	620 0.5×	477 0.6×	290 1.0×	45 0.3×	77	1.8k
Debra Chester Kalter United States	22	645 0.4×	1.1k 0.8×	522 0.7×	216 0.7×	57 0.3×	34	1.8k
Valeria Falcone Germany	22	640 0.4×	271 0.2×	850 1.1×	200 0.7×	58 0.3×	46	1.6k
Alain Venet France	32	1.1k 0.7×	2.3k 1.8×	666 0.8×	311 1.0×	100 0.6×	59	3.1k

Countries citing papers authored by P Schipper

Since Specialization

Citations

This map shows the geographic impact of P Schipper's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P Schipper with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P Schipper more than expected).

Fields of papers citing papers by P Schipper

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P Schipper. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P Schipper. The network helps show where P Schipper may publish in the future.

Co-authorship network of co-authors of P Schipper

This figure shows the co-authorship network connecting the top 25 collaborators of P Schipper. A scholar is included among the top collaborators of P Schipper based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P Schipper. P Schipper is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Schipper, P, Lavina Gharu, Gijsje J. L. Snijders, et al.. (2025). Microglia Exhibit a Unique Intact HIV Reservoir in Human Postmortem Brain Tissue. Viruses. 17(4). 467–467. 1 indexed citations

Mudrikova, Tania, P Schipper, Andy I. M. Hoepelman, et al.. (2024). Characterization of HIV variants from paired Cerebrospinal fluid and Plasma samples in primary microglia and CD4+ T-cells. Journal of NeuroVirology. 30(4). 380–392. 1 indexed citations

Berlekom, Amber Berdenis van, Raphael Kübler, P Schipper, et al.. (2022). Characterization of HIV-1 Infection in Microglia-Containing Human Cerebral Organoids. Viruses. 14(4). 829–829. 47 indexed citations

Kübler, Raphael, Lavina Gharu, P Schipper, et al.. (2022). Human microglial models to study HIV infection and neuropathogenesis: a literature overview and comparative analyses. Journal of NeuroVirology. 28(1). 64–91. 26 indexed citations

Connell, Bridgette J., Lucas E. Hermans, Annemarie M. J. Wensing, et al.. (2020). Immune activation correlates with and predicts CXCR4 co-receptor tropism switch in HIV-1 infection. Scientific Reports. 10(1). 15866–15866. 24 indexed citations

Zhang, Xichen, Dorothee Wasserberg, Bridgette J. Connell, et al.. (2020). An inkjet-printed polysaccharide matrix for on-chip sample preparation in point-of-care cell counting chambers. RSC Advances. 10(31). 18062–18072. 3 indexed citations

Fun, Axel, Thomas Leitner, Linos Vandekerckhove, et al.. (2018). Impact of the HIV-1 genetic background and HIV-1 population size on the evolution of raltegravir resistance. Retrovirology. 15(1). 1–1. 10 indexed citations

Hofstra, L. Marije, Monique Nijhuis, Tania Mudrikova, et al.. (2014). Use of dolutegravir in two INI‐experienced patients with multiclass resistance resulted in excellent virological and immunological responses. Journal of the International AIDS Society. 17(4S3). 19755–19755. 3 indexed citations

Maarseveen, Noortje M. van, Dan I. Andersson, Martin Lepšı́k, et al.. (2012). Modulation of HIV-1 Gag NC/p1 cleavage efficiency affects protease inhibitor resistance and viral replicative capacity. Retrovirology. 9(1). 29–29. 11 indexed citations

10.

Fun, Axel, Noortje M. van Maarseveen, Jana Pokorná, et al.. (2011). HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat. Retrovirology. 8(1). 70–70. 21 indexed citations

11.

Fun, Axel, Karen Van Baelen, S.F.L. van Lelyveld, et al.. (2010). Mutation Q95K enhances N155H-mediated integrase inhibitor resistance and improves viral replication capacity. Journal of Antimicrobial Chemotherapy. 65(11). 2300–2304. 13 indexed citations

12.

Elden, Leontine J. R. van, A. P. E. Sachs, Anton M. van Loon, et al.. (2007). Enhanced severity of virus associated lower respiratory tract disease in asthma patients may not be associated with delayed viral clearance and increased viral load in the upper respiratory tract. Journal of Clinical Virology. 41(2). 116–121. 35 indexed citations

13.

Nijhuis, Monique, Noortje M. van Maarseveen, Stéphane Lastère, et al.. (2007). A Novel Substrate-Based HIV-1 Protease Inhibitor Drug Resistance Mechanism. PLoS Medicine. 4(1). e36–e36. 138 indexed citations

14.

Elden, Leontine J. R. van, Anton M. van Loon, Andy I. M. Hoepelman, et al.. (2004). Frequent Detection of Human Coronaviruses in Clinical Specimens from Patients with Respiratory Tract Infection by Use of a Novel Real‐Time Reverse‐Transcriptase Polymerase Chain Reaction. The Journal of Infectious Diseases. 189(4). 652–657. 162 indexed citations

15.

Nijhuis, Monique, Rob Schuurman, Dorien de Jong, et al.. (1999). Increased fitness of drug resistant HIV-1 protease as a result of acquisition of compensatory mutations during suboptimal therapy. AIDS. 13(17). 2349–2359. 305 indexed citations

16.

Schuurman, Rob, Monique Nijhuis, Remko van Leeuwen, et al.. (1995). Rapid Changes in Human Immunodeficiency Virus Type 1 RNA Load and Appearance of Drug-Resistant Virus Populations in Persons Treated with Lamivudine (3TC). The Journal of Infectious Diseases. 171(6). 1411–1419. 417 indexed citations

17.

Jong, Menno D. de, Mark Loewenthal, Charles A. Boucher, et al.. (1994). Alternating Nevirapine and Zidovudine Treatment of Human Immunodeficiency Virus Type 1-Infected Persons Does Not Prolong Nevirapine Activity. The Journal of Infectious Diseases. 169(6). 1346–1350. 20 indexed citations

18.

Boucher, Charles A., Remko van Leeuwen, Paul Kellam, et al.. (1993). Effects of discontinuation of zidovudine treatment on zidovudine sensitivity of human immunodeficiency virus type 1 isolates. Antimicrobial Agents and Chemotherapy. 37(7). 1525–1530. 47 indexed citations

19.

Boucher, Charles A., N. Cammack, P Schipper, et al.. (1993). High-level resistance to (-) enantiomeric 2'-deoxy-3'-thiacytidine in vitro is due to one amino acid substitution in the catalytic site of human immunodeficiency virus type 1 reverse transcriptase. Antimicrobial Agents and Chemotherapy. 37(10). 2231–2234. 263 indexed citations

20.

Bot, FJ, Lucas van Eijk, P Schipper, & Bob Löwenberg. (1989). Effects of human interleukin-3 on granulocytic colony-forming cells in human bone marrow. Blood. 73(5). 1157–1160. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact